Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
| Autor: | Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar |
|---|---|
| Zdroj: | In Clinical Microbiology and Infection February 2023 29(2):215-220 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|